| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 156.0K | $8.64M | - | |
| CEO | 99.9K | $5.53M | - | |
| CFO | 82.7K | $4.58M | - | |
| VP | 74.4K | $4.12M | - | |
| VP | 69.7K | $3.86M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Klein Joseph III60 | Director | Sale+OE | 28,000 | $60.00 | $1,680,000.00 | -100% | +34.4% | - | |
| Sep 3, 2025 | Wender Joseph H | Director | Sell | 28,000 | $57.58 | $1,612,155.44 | -7.3% | +34.4% | - | |
| Sep 3, 2025 | Wender Joseph H | Director | Sell | 28,000 | $57.58 | $1,612,155.44 | -7.3% | +34.4% | - | |
| Sep 3, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 89,900 | $60.03 | $5,396,843.39 | -56.2% | +34.4% | - | |
| Sep 3, 2025 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 38,909 | $59.14 | $2,301,263.58 | -17.0% | +34.4% | - | |
| Sep 2, 2025 | Swayze Eric63 | EVP Research | Sell | 11,130 | $49.67 | $552,861.68 | -12.8% | +42.6% | - | |
| Sep 2, 2025 | Parshall B Lynne74 | Director | Sell | 20,000 | $50.91 | $1,018,297.50 | -12.4% | +42.6% | - | |
| Sep 2, 2025 | Geary Richard S65 | EVP, Chief Development Officer | Sell | 10,000 | $50.37 | $503,671.00 | -11.2% | +42.6% | - | |
| Aug 22, 2025 | Diaz Allene M. | Director | Sell | 1,427 | $42.53 | $60,687.17 | -7.2% | +71.3% | - | |
| Aug 18, 2025 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 10,000 | $43.98 | $439,776.00 | -9.7% | +68.7% | - |